Demystified ... cell cycle.

Por Gillett, C E, Barnes, D M
Publicado em 1998

Determination of cell proliferation

Por Barnes, D M, Gillett, C E
Publicado em 1995

Oestrogen and progesterone receptor expression in mammary fibromatosis.

Por Rasbridge, S A, Gillett, C E, Millis, R R
Publicado em 1993

Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma.

Por Gillett, C E, Barnes, D M, Camplejohn, R S
Publicado em 1993

Cell proliferation measured by MIB1 and timing of surgery for breast cancer.

Por Cooper, L. S., Gillett, C. E., Smith, P., Fentiman, I. S., Barnes, D. M.
Publicado em 1998

Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.

Por Fisher, C. J., Gillett, C. E., Vojtĕsek, B., Barnes, D. M., Millis, R. R.
Publicado em 1994

Patterns of metastasis in women with metachronous contralateral breast cancer

Por Vichapat, V, Garmo, H, Holmberg, L, Fentiman, I S, Tutt, A, Gillett, C, Lüchtenborg, M
Publicado em 2012

High-throughput optical proteomics and breast cancer patient profiling: novel applications to individualise prognosis and treatment

Por Kelleher, MT, Festy, F, Gillett, C, Pinder, SE, Ameer-Beg, S, Fo, EO, Ellis, PA, Ng, T
Publicado em 2008

Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.

Por Camplejohn, R. S., Brock, A., Barnes, D. M., Gillett, C., Raikundalia, B., Kreipe, H., Parwaresch, M. R.
Publicado em 1993

New molecular tools and optical technologies to dissect CXCR4 function in breast cancer

Por Thavasu, PW, Festy, F, Springall, R, Ryder, K, Waters, R, Kelleher, M, Pinder, S, Gillett, C, Ng, T
Publicado em 2006

Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer

Por Yates, LR, Jones, A, Patel, H, Mackay, A, Gillett, C, Pinder, S, Tomlinson, I, Roylance, R, Sawyer, EJ
Publicado em 2010

The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma.

Por Rasbridge, S. A., Gillett, C. E., Seymour, A. M., Patel, K., Richards, M. A., Rubens, R. D., Millis, R. R.
Publicado em 1994

Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer

Por Wong, P-P, Yeoh, C C, Ahmad, A S, Chelala, C, Gillett, C, Speirs, V, Jones, J L, Hurst, H C
Publicado em 2014

The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.

Por Camplejohn, R. S., Ash, C. M., Gillett, C. E., Raikundalia, B., Barnes, D. M., Gregory, W. M., Richards, M. A., Millis, R. R.
Publicado em 1995

King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB)

Por Saifuddin, S. R., Devlies, W., Santaolalla, A., Cahill, F., George, G., Enting, D., Rudman, S., Cathcart, P., Challacombe, B., Dasgupta, P., Galustian, C., Chandra, A., Chowdhury, S., Gillett, C., Van Hemelrijck, M.
Publicado no BMC Cancer (2017)

A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH

Por Roylance, R, Gorman, P, Papior, T, Wan, Y-L, Ives, M, Watson, JE, Collins, C, Wortham, N, Langford, C, Fiegler, H, Carter, N, Gillett, C, Sasieni, P, Pinder, S, Hanby, A, Tomlinson, I
Publicado em 2006

Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE

Por Carmona, G, Perera, U, Gillett, C, Naba, A, Law, A-L, Sharma, V P, Wang, J, Wyckoff, J, Balsamo, M, Mosis, F, De Piano, M, Monypenny, J, Woodman, N, McConnell, R E, Mouneimne, G, Van Hemelrijck, M, Cao, Y, Condeelis, J, Hynes, R O, Gertler, F B, Krause, M
Publicado no Oncogene (2016)